Item 2.02 - Results of Operations and Financial Condition: The filing discloses financial results and operational performance information for Cardinal Health, Inc. Item 7.01 - Regulation FD Disclosure: The company is making additional disclosures in compliance with Regulation Fair Disclosure requirements. Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and…

Our analysis rates this filing BULLISH. Cardinal Health's Q2 FY2026 earnings announcement presents an exceptionally strong financial picture with no material concerns. The company delivered substantial earnings beats with 19% revenue growth and 38% non-GAAP operating earnings growth—a clear margin…

Concern level: LOW (1.5/10).

Notable risk changes: Strong financial performance with 19% revenue growth to $65.6B and 38% non-GAAP operating earnings growth - positive momentum; Raised FY2026 non-GAAP EPS guidance to $10.15-$10.35 range, indicating management confidence in outlook; Achieved targeted leverage range and completed $750M baseline share repurchase, demonstrating financial strength and capital allocation discipline.

The model predicts CAH will underperform the S&P 500 by about 0.1% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.